|4Jun 21, 4:52 PM ET

Johnston Douglas 4

4 · LIPELLA PHARMACEUTICALS INC · Filed Jun 21, 2023

Insider Transaction Report

Form 4
Period: 2023-06-16
Johnston Douglas
Chief Financial Officer
Transactions
  • Award

    Options to Purchase

    2023-06-16+50,00050,000 total
    Exercise: $2.19From: 2023-06-16Exp: 2033-06-16Common Stock (50,000 underlying)

Documents

1 file
  • 4
    ownership.xmlPrimary